CompletedPHASE1, PHASE2NCT01733407
L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1
Studying Hereditary sensory and autonomic neuropathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts General Hospital
- Principal Investigator
- Florian S Eichler, MDMassachusetts General Hospital
- Intervention
- L-serine(drug)
- Enrollment
- 18 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2017
Study locations (2)
- Massachusetts General Hospital, Boston, Massachusetts, United States
- UMass Medical Center, Worcester, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01733407 on ClinicalTrials.gov